Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
23.85
+0.87 (3.79%)
At close: Jul 15, 2026, 4:00 PM EDT
23.39
-0.46 (-1.93%)
After-hours: Jul 15, 2026, 7:08 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $2.48 billion as of July 15, 2026. Its market cap has increased by 185.05% in one year.
Market Cap
2.48B
Enterprise Value
2.09B
1-Year Change
185.05%
Ranking
Category
Stock Price
$23.85
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $2.48B, an increase of 251.54%. That is a compound annual growth rate of 23.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 2.48B | 28.72% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vericel | 2.42B |
| Pharvaris | 2.42B |
| Agios Pharmaceuticals | 2.40B |
| Trevi Therapeutics | 2.35B |
| Nektar Therapeutics | 2.32B |
| Biohaven | 2.30B |
| Zai Lab | 2.22B |
| Ocular Therapeutix | 2.17B |